We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel 3D Printing Technique Installs NIV Sensors in Lab-on-a Chip Devices

By LabMedica International staff writers
Posted on 04 Nov 2016
A team of biomedical engineers developed an advanced three-dimensional (3D) printing technique to embed noninvasive strain sensors into living tissue as an integral component of organ-on-a-chip devices.

Microphysiological systems (MPS), also known as organs-on-chips, that recapitulate the structure and function of native tissues in vitro, have emerged as a promising alternative to the use of animals in biomedical investigations. More...
However, current MPS typically lack integrated sensors and their fabrication requires complex and expensive multi-step lithographic processes.

Investigators at Harvard University (Cambridge, MA, USA) recently described a method for fabricating a new class of instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Specifically, they designed six functional inks, based on piezo-resistive, high-conductance, and biocompatible soft materials that enabled integration of soft strain gauge sensors within micro-architectures that guided the self-assembly of laminar cardiac tissues.

As described in the October 24, 2016, online edition of the journal Nature Materials, the chips contained multiple wells, each with separate tissues and integrated sensors, allowing investigators to study many engineered cardiac tissues at once.

The investigators validated that the embedded sensors provided non-invasive, electronic readouts of tissue contractile stresses inside cell incubator environments. They further applied these devices to study drug responses, as well as the contractile development of human stem cell-derived laminar cardiac tissues over four weeks.

"Our microfabrication approach opens new avenues for in vitro tissue engineering, toxicology, and drug screening research," said senior author Dr. Kit Parker, professor of bioengineering and applied physics at Harvard University. "Translating microphysiological devices into truly valuable platforms for studying human health and disease requires that we address both data acquisition and manufacturing of our devices. This work offers new potential solutions to both of these central challenges."

Related Links:
Harvard University


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
Multichem ID-B
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.